I am a
Home I AM A Search Login

Papers of the Week

Papers: 17 Jul 2021 - 23 Jul 2021

Human Studies, Pharmacology/Drug Development


2021 Jul 16

Brain Behav

Predictors of response to erenumab after 12 months of treatment.


Baraldi C, Lo Castro F, Cainazzo M M, Pani L, Guerzoni S
Brain Behav. 2021 Jul 16.
PMID: 34268907.


Erenumab is a monoclonal antibody acting against calcitonin gene-related peptide receptor and approved for the preventive treatment of chronic migraine. The aim of the present study is to identify clinical predictors of good response in patients with chronic migraine and medication overuse-headache.